Pharmaceutical composition comprising a combination of an antimicrobial Agent and a selective inhibitor of the Enzyme encefalinasa indicated for the Control and Treatment of acute bacterial diarrhea

摘要

Claim 1: a Pharmaceutical composition characterized in that it comprises a synergistic combination of an antimicrobial Agent, as is the active principle Agent: Ciprofloxacin and a selective inhibitor of the Enzyme encefalinasa, being the active Principle: racecadotril Or,In addition to pharmaceutically acceptable excipients; where the active ingredients present in the formulation in a Concentration range from 8.0 mg. Up to 1.0 g to ciprofloxacin and 100.0 mg. Up to 30.0 mg.For the racecadotril; these are formulated in a single Dosing Unit to be administered orally, which is indicated for the Control and Treatment of acute bacterial diarrhea.